Citigroup Inc Astrazeneca PLC Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Citigroup Inc holds 3,822,870 shares of AZN stock, worth $342 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

3,822,870

Previous 923,998 313.73%

Holding current value

$342 Million

Previous $64.6 Million 354.23%

% of portfolio

0.14%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$68.72 - $82.11 $199 Million - $238 Million	2,898,872 Added 313.73%	3,822,870 $293 Million
Q2 2025 Aug 11, 2025	BUY	$64.87 - $75.0 $8.76 Million - $10.1 Million	135,107 Added 17.13%	923,998 $64.6 Million
Q1 2025 May 12, 2025	SELL	$65.37 - $77.96 $2.24 Million - $2.67 Million	-34,233 Reduced 4.16%	788,891 $58 Million
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $45.6 Million - $57.4 Million	-721,238 Reduced 46.7%	823,124 $53.9 Million
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $8.33 Million - $9.52 Million	108,617 Added 7.57%	1,544,362 $120 Million

Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $38.1 Million - $46.1 Million	570,510 Added 65.94%	1,435,745 $112 Million
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $12 Million - $13.7 Million	196,291 Added 29.34%	865,235 $58.6 Million
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $3.96 Million - $4.43 Million	-63,977 Reduced 8.73%	668,944 $45.1 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $3.47 Million - $3.84 Million	53,536 Added 7.88%	732,921 $49.6 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $39 Million - $42.3 Million	-558,120 Reduced 45.1%	679,385 $48.6 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $19.3 Million - $21.9 Million	305,420 Added 32.77%	1,237,505 $85.9 Million
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $22.6 Million - $29.4 Million	417,526 Added 81.14%	932,085 $63.2 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $7.69 Million - $19.7 Million	145,093 Added 39.27%	514,559 $28.2 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $10.9 Million - $13 Million	-183,275 Reduced 33.16%	369,466 $24.4 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $2.98 Million - $3.59 Million	53,529 Added 10.72%	552,741 $36.7 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $11.6 Million - $13.7 Million	-214,886 Reduced 30.09%	499,212 $29.1 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $39.7 Million - $43.4 Million	714,098 New	714,098 $42.9 Million

Others Institutions Holding AZN

# of Institutions

1,502

Shares Held

500M

Call Options Held

5.64M

Put Options Held

3.2M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account